Multicenter cohort study identifying prognostic factors in patients with polymyositis/dermatomyositis and interstitial lung disease

Multicenter cohort study identifying prognostic factors in patients with polymyositis/dermatomyositis and interstitial lung disease - PM/DM-ILD cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018663

Enrollment

400

Registered

2015-08-24

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polymyositis/dermatomyositis with interstitial lung disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age equal or greater than 16 years 2. Clinical diagnosis of polymyositis or dermatomyositis, including clinically amyopathic dermatomyositis 3. Presence of interstitial lung disease by chest X ray or high-resolution CT scan 4. myositis-specific autoantibody identified or availability of serum samples used for identification of myositis-specific autoantibodies

Exclusion criteria

Exclusion criteria: Observation period < 6 months unless death

Design outcomes

Primary

Measure	Time frame
Survival at 3, 6, and 12 months	—

Countries

Japan

Contacts

Public ContactMasataka Kuwana

Nippon Medical School Department of Allergy and Rheumatology

kuwanam@nms.ac.jp03-3822-2131

Outcome results